22nd Century Group, Inc.(NYSE Amex Equities : XXII)
(
)
Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| MRNA | Moderna, Inc. | 0.80% | 61.58 | 0.0% | $914.89m | |
| NVAX | Novavax, Inc. | -5.99% | 98.30 | 102.0% | $790.47m | |
| AMGN | Amgen, Inc. | -0.62% | 251.59 | 1.3% | $725.25m | |
| REGN | Regeneron Pharmaceuticals, Inc. | -0.08% | 640.34 | 2.5% | $677.64m | |
| GILD | Gilead Sciences, Inc. | -1.06% | 75.61 | 1.0% | $627.17m | |
| BIIB | Biogen, Inc. | 4.41% | 280.19 | 1.6% | $622.60m | |
| VRTX | Vertex Pharmaceuticals, Inc. | -1.05% | 295.92 | 1.9% | $509.00m | |
| ILMN | Illumina, Inc. | -0.61% | 369.87 | 3.5% | $300.06m | |
| ALXN | Alexion Pharmaceuticals, Inc. | -3.97% | 108.00 | 2.0% | $219.47m | |
| BMRN | BioMarin Pharmaceutical, Inc. | 0.59% | 128.73 | 4.3% | $214.30m | |
| SGEN | Seattle Genetics, Inc. | -0.35% | 175.53 | 6.1% | $200.21m | |
| SRNE | Sorrento Therapeutics, Inc. | -1.22% | 7.29 | 1.8% | $180.15m | |
| IMMU | Immunomedics, Inc. | 0.95% | 41.55 | 11.0% | $179.47m | |
| SRPT | Sarepta Therapeutics, Inc. | 3.82% | 170.15 | 13.9% | $164.96m | |
| ALNY | Alnylam Pharmaceuticals, Inc. | 0.26% | 160.42 | 8.5% | $164.06m |
Company Profile
22nd Century Group, Inc. is a plant biotechnology company, which engages in the development of technology that will allow increasing or decreasing the level of nicotine and nicotinic alkaloids in tobacco plants and levels of cannabinoids in cannabis plants through genetic engineering and plant breeding. Its products include X-22, modified risk cigarettes, spectrum government research cigarettes, magic 0 and magic 2, moonlight, red sun, variable nicotine-level research cigarettes, and verfola. The company was founded on September 12, 2005 and is headquartered in Clarence, NY.